Dar Al Dawa Development and Investment Co. Ltd. (ASE: DADI)
Health Care · Pharmaceuticals · JO
JD1.25
+1.63% today · +7.8% 1Y
Dar Al Dawa Development and Investment Co. Ltd. (ASE: DADI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $88.16M.
Over the last twelve months the share price has gained 7.8%, trading between 1.10 and 1.31.
Tweenvest scores Dar Al Dawa Development and Investment Co. Ltd. across four factors: quality 72/100, value 72/100, dividend 89/100. Its strongest factor is dividend.
DADI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $88.16M
- Revenue (TTM)
- $113.76M
- P/E
- 7.63
- EPS
- 0.16
- Dividend yield
- 2.40%
- Beta (5Y)
- 0.18
- 52-week high
- JD1.31
- 52-week low
- JD1.10
- Avg volume (3M)
- —
- Shares outstanding
- 50.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shree Ganesh Remedies LimitedBSE: 540737 | $90.37M | Rs681.25 | -1.72% |
| Renascience Inc.TSE: 4889 | $89.79M | ¥1,032.00 | -6.44% |
| Dong Sung Bio Pharm.Co.,Ltd.KOSE: A002210 | $89.60M | ₩1,283.00 | +0.39% |
| Neumora Therapeutics, Inc.NasdaqGS: NMRA | $89.38M | $0.44 | -8.05% |
| Hyphens Pharma International LimitedCatalist: 1J5 | $88.02M | S$0.37 | +2.82% |
| Kilitch Drugs (India) LimitedBSE: 524500 | $87.67M | Rs242.70 | +12.34% |
| HLS Therapeutics Inc.TSX: HLS | $87.26M | CA$4.09 | +5.68% |
| Lee's Pharmaceutical Holdings LimitedSEHK: 950 | $86.29M | HK$1.15 | -1.71% |
Figures last refreshed Oct 11, 2026.